Literature DB >> 2166159

Lymphoproliferative responses in recrudescent orofacial herpetic infections.

J P Vestey1, M Norval, S E Howie.   

Abstract

The relationship between antibody (Ab) and lympho-proliferative responses to herpes simplex virus (HSV) and recrudescent orofacial HSV lesions were investigated in 65 patients. All had HSV-specific Ab and cell mediated immune responses (CMIR) demonstrated by ELISA and in vitro lymphoproliferation respectively. Thirteen control subjects were negative in both tests. Thirty-three patients were repeatedly investigated for 6-38 months during which time they suffered 1-8 recrudescences. HSV-induced lymphoproliferation was depressed during recrudescences, rose to a peak several weeks later, and declined slowly to a background level. However, ELISA titres and lymphoproliferative responses to Concanavalin A (Con A) were high throughout and circulating peripheral blood mononuclear cell (PBMC) subsets did not change. Depressed lymphoproliferative responses to HSV antigen (Ag) during recrudescences were enhanced by removal of CD8+ cells from PBMC using either a panning technique or cell sorting; reconstitution of CD8+ cells suppressed the HSV-specific lymphoproliferative response. CD8+ cell depletion affected neither HSV-induced lymphoproliferation recrudescence, nor lymphoproliferative responses to another Ag (PPD) during recrudescence. Depressed HSV-induced lymphoproliferation during recrudescences might thus be due to CD8+ suppressor T cell (Ts) function rather than low numbers of circulating lymphocytes. Suppression or delay of normal CMIR to asymptomatic recurrent epidermal HSV infection by Ts might allow development of recrudescent HSV lesions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166159      PMCID: PMC1292650          DOI: 10.1177/014107689008300510

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  14 in total

1.  Variation in lymphoproliferative responses during recrudescent orofacial herpes simplex virus infections.

Authors:  J P Vestey; M Norval; S Howie; J Maingay; W A Neill
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

2.  Cellular immune response in genital herpes simplex virus infection.

Authors:  L Corey; W C Reeves; K K Holmes
Journal:  N Engl J Med       Date:  1978-11-02       Impact factor: 91.245

3.  Depressed herpes simplex virus-induced lymphocyte blastogenesis in individuals with severe recurrent herpes infections.

Authors:  I I El Araby; M A Chernesky; W E Rawls; P B Dent
Journal:  Clin Immunol Immunopathol       Date:  1978-02

Review 4.  The host response to herpes simplex virus.

Authors:  P Wildy; P G Gell
Journal:  Br Med Bull       Date:  1985-01       Impact factor: 4.291

Review 5.  Infections with herpes simplex viruses (1).

Authors:  L Corey; P G Spear
Journal:  N Engl J Med       Date:  1986-03-13       Impact factor: 91.245

6.  Reactivation of herpes simplex virus is associated with production of a low molecular weight factor that inhibits lymphokine activity in vitro.

Authors:  J F Sheridan; M Beck; C C Smith; L Aurelian
Journal:  J Immunol       Date:  1987-02-15       Impact factor: 5.422

7.  Immunity to herpes simplex virus type 2. IV. Impaired lymphokine production during recrudescence correlates with an imbalance in T lymphocyte subsets.

Authors:  J F Sheridan; A D Donnenberg; L Aurelian; D J Elpern
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

8.  Cell-mediated immunity against herpes simplex virus envelope, capsid, excreted, and crude antigens.

Authors:  K O Kalimo; I A Joronen; V K Havu
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

9.  Viral inhibition of lymphocyte proliferative responsiveness in patients suffering from recurrent lesions caused by herpes simplex virus.

Authors:  M A Wainberg; J D Portnoy; B Clecner; S Hubschman; J Lagacé-Simard; N Rabinovitch; Z Remer; J Mendelson
Journal:  J Infect Dis       Date:  1985-09       Impact factor: 5.226

10.  Immune responses to herpes simplex virus in patients with recurrent herpes labialis: I. Development of cell-mediated cytotoxic responses.

Authors:  H Tsutsumi; J M Bernstein; M Riepenhoff-Talty; E Cohen; F Orsini; P L Ogra
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

View more
  2 in total

1.  Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8+ cytotoxic T lymphocyte responses.

Authors:  C M Posavad; D M Koelle; M F Shaughnessy; L Corey
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

2.  Expression of cutaneous lymphocyte-associated antigen and E-selectin ligand by circulating human memory CD4+ T lymphocytes specific for herpes simplex virus type 2.

Authors:  Julio C González; William W Kwok; Anna Wald; Christopher L McClurkan; Jay Huang; David M Koelle
Journal:  J Infect Dis       Date:  2004-12-15       Impact factor: 5.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.